|
atp metabolic process
|
GO:0046034 |
75 |
0.562
|
Human |
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.333
|
Human |
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.259
|
Human |
|
negative regulation of nitric oxide synthase biosynthetic process
|
GO:0051771 |
1 |
0.255
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.231
|
Human |
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.221
|
Human |
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.215
|
Human |
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.190
|
Human |
|
male gamete generation
|
GO:0048232 |
285 |
0.185
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.175
|
Human |
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.169
|
Human |
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.166
|
Human |
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.148
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.144
|
Human |
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.134
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.127
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.117
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.105
|
Human |
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.084
|
Human |
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.083
|
Human |
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.082
|
Human |
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.078
|
Human |
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.070
|
Human |
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.070
|
Human |
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.069
|
Human |
|
synaptic transmission
|
GO:0007268 |
329 |
0.068
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.062
|
Human |
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.061
|
Human |
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.058
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.057
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.056
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.050
|
Human |
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.049
|
|
|
cation transport
|
GO:0006812 |
399 |
0.047
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.047
|
Human |
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.044
|
|
|
succinate transport
|
GO:0015744 |
1 |
0.041
|
|
|
gonad development
|
GO:0008406 |
141 |
0.040
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.039
|
|
|
mitochondrial electron transport ubiquinol to cytochrome c
|
GO:0006122 |
2 |
0.039
|
|
|
placenta development
|
GO:0001890 |
140 |
0.038
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.037
|
Human |
|
hydrogen ion transmembrane transport
|
GO:1902600 |
25 |
0.037
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.037
|
Human |
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.036
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.034
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.033
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.033
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.032
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.032
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.031
|
Human |
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.031
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.030
|
|
|
oxidative phosphorylation
|
GO:0006119 |
14 |
0.029
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.029
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.028
|
|
|
determination of adult lifespan
|
GO:0008340 |
11 |
0.028
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.027
|
Human |
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.027
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.027
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.026
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.026
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.026
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.025
|
|
|
amide transport
|
GO:0042886 |
138 |
0.024
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.024
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.024
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.024
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.023
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.023
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.022
|
Human |
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.022
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.022
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.021
|
Human |
|
decidualization
|
GO:0046697 |
10 |
0.021
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.020
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.020
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.020
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.020
|
|
|
pyridine containing compound metabolic process
|
GO:0072524 |
14 |
0.019
|
|
|
multicellular organismal aging
|
GO:0010259 |
24 |
0.019
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.019
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.019
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.019
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.019
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.018
|
Human |
|
positive regulation of retinal ganglion cell axon guidance
|
GO:1902336 |
2 |
0.018
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.018
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.018
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.018
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.018
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.018
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.017
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.017
|
Human |
|
muscle tissue development
|
GO:0060537 |
308 |
0.017
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.017
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.017
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.017
|
Human |
|
cardiac cell fate specification
|
GO:0060912 |
2 |
0.017
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.017
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.017
|
|
|
response to heat
|
GO:0009408 |
27 |
0.017
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.016
|
Human |
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.016
|
|
|
nadh metabolic process
|
GO:0006734 |
1 |
0.016
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.016
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
57 |
0.016
|
Human |
|
organic heteropentacyclic compound catabolic process
|
GO:1901377 |
1 |
0.016
|
|
|
dicarboxylic acid catabolic process
|
GO:0043649 |
2 |
0.016
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.015
|
Human |
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.015
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.015
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.015
|
|
|
secondary metabolite catabolic process
|
GO:0090487 |
1 |
0.015
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.015
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.015
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.015
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.015
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.015
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.015
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.015
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.015
|
Human |
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.014
|
|
|
c4 dicarboxylate transport
|
GO:0015740 |
3 |
0.014
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.014
|
|
|
negative regulation of purine nucleotide catabolic process
|
GO:0033122 |
9 |
0.014
|
|
|
receptor localization to synapse
|
GO:0097120 |
4 |
0.014
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.014
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.014
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.014
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.014
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.014
|
Human |
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.014
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.014
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.013
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.013
|
|
|
positive regulation of ruffle assembly
|
GO:1900029 |
1 |
0.013
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.013
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.013
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.013
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.013
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.013
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.013
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.013
|
|
|
cellular respiration
|
GO:0045333 |
38 |
0.013
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.013
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.013
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.013
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.013
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.013
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.012
|
Human |
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.012
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.012
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.012
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.012
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.012
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.012
|
Human |
|
lipid localization
|
GO:0010876 |
126 |
0.012
|
|
|
neuron neuron synaptic transmission
|
GO:0007270 |
69 |
0.012
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.012
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.012
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.012
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.011
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.011
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.011
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.011
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.011
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.011
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.011
|
|
|
regulation of superoxide anion generation
|
GO:0032928 |
4 |
0.011
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.011
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.011
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.011
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.011
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.011
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.011
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.011
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.011
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.011
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.011
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.010
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.010
|
|
|
phosphate ion transport
|
GO:0006817 |
3 |
0.010
|
|
|
cellular response to epidermal growth factor stimulus
|
GO:0071364 |
4 |
0.010
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.010
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.010
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.010
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.010
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.010
|
|
|
response to uv
|
GO:0009411 |
44 |
0.010
|
|